Current Affairs21 Nov, 2026PIBIndia Emerging as a …
GS 2: GovernanceGS 3: Science & TechnologyGS 2: Social JusticePrelimsGS 3: Achievements of Indians in Science and Technology

India Emerging as a Global Research Hub for Diabetes, Genetic Disorders and Next-Generation Healthcare Solutions: Dr. Jitendra Singh

Dr. Jitendra Singh announces India's rise as a global research hub for diabetes, genetic disorders, and next-gen healthcare, emphasizing indigenous solutions and genetic diversity.

Practice MCQs

767 Students attempted
Attempt Now

Key Highlights:

  • India is emerging as a global research hub for diabetes, genetic disorders, and next-generation healthcare solutions.
  • Over a dozen diabetes-related research projects are underway under the Ministry of Science & Technology, primarily through DBT and CSIR.
  • Research focuses on prevention and control of diabetes via molecular and genetic solutions, leveraging India's vast population and genetic diversity.
  • The India Genome Study, involving 10,000 individuals across 84 population groups, serves as a key resource for advancing precision medicine.
  • India has transformed from external dependence to developing indigenous vaccines, therapies, antibiotics, and advanced medical technologies.
  • Emphasis on preventing obesity and diabetes among youth is a national responsibility for achieving Viksit Bharat by 2047.
  • Greater collaboration between government, private sector, startups, and medical associations is encouraged for translational research.

Detailed Insights:

  • India's scientific and healthcare capabilities have significantly transformed, moving towards indigenous solutions like DNA-based COVID-19 vaccine and genetic therapy research.
  • Precision medicine and molecular-level interventions are opening new avenues for understanding Type 2 diabetes and associated metabolic disorders.
  • An Indo-Danish collaborative study examines India-specific changes in gut microbiota among prediabetic and diabetic patients.
  • DBT supports research on genetically engineered E. coli Nissle 1917 for probiotic-based delivery of therapeutic molecules like GLP-1.
  • The EINSTEIN study in rural Mysuru explores preconception-to-early-childhood interventions to reduce cardiometabolic risks.
  • Research identifies biomarkers for Type 2 diabetes in women with gestational diabetes and investigates links with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).
  • Emerging research on macrophage Gi signalling is a potential therapeutic target for obesity and Type 2 diabetes.
  • Efforts are underway to develop temperature-resilient insulin and oral insulin, supported by institutional backing and startups.
  • India has made progress in indigenous biosimilar development, including liraglutide and insulin Lispro, for affordable diabetes treatment.
  • The Minister urged the medical and scientific fraternity to counter misinformation regarding diabetes, obesity, and nutrition.

Scientific/Technical Concepts Involved:

  • DBT (Department of Biotechnology): A government department under the Ministry of Science & Technology, supporting research and development in biotechnology.
  • CSIR (Council of Scientific & Industrial Research): India's largest research and development organization, involved in various scientific and industrial fields.
  • Viksit Bharat by 2047: A vision for India to become a developed nation by its 100th year of independence.
  • Precision Medicine: An approach to disease treatment and prevention that considers individual variability in genes, environment, and lifestyle.
  • Biosimilars: Biological products highly similar to an already approved biological medicine, offering affordable alternatives.
  • GLP-1 (Glucagon-like peptide-1): A hormone that plays a crucial role in regulating blood sugar levels and appetite.
  • Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A chronic liver condition characterized by fat accumulation in the liver, not caused by excessive alcohol.
SuperKalam
SuperKalam is your personal mentor for UPSC preparation, guiding you at every step of the exam journey.

Download the App

Get it on Google PlayDownload on the App Store
Follow us

ⓒ Snapstack Technologies Private Limited